CIK 0001799191 · Accelerated filer<br>Smaller reporting company
Starling Oncology, Inc.
Sign in to watch- Tickers
- STLN DFPH
- Exchange
- Nasdaq, OTC
- Industry
- Services-Offices & Clinics of Doctors of Medicine
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 843562323
- Phone
- 562-735-3226
- Business address
- 18000 STUDEBAKER RD, SUITE 800, CERRITOS, CA, 90703
- Former names
- Oncology Institute, Inc., DFP HEALTHCARE ACQUISITIONS CORP.
Securities
- STLN Common Stock Nasdaq
- STLNW Warrant Nasdaq
- DFPH Common stock OTC
- 4 Other disposition Chief Financial Officer disposed of 1,314 shares (other)
- 4 Other disposition Chief Medical Officer disposed of 3,420 shares (other)
- 4 Open-market buy 10% owner bought 398,985 shares at an average $3.07 ($1,225,101)
- 3 Insider Initial Statement of Ownership
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 8-K Event Regulation FD disclosure
- 10-K Report Annual Report
- 8-K Event Results of operations
- 8-K Event Executive or director change · Regulation FD disclosure
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- 3 Insider Initial Statement of Ownership
- 8-K Event Results of operations
- 8-K Event Executive or director change · Regulation FD disclosure
- 4/A Other disposition Chief Financial Officer disposed of 244 shares (other)
- 4 Open-market sale Chief Financial Officer sold 247 shares at $3.56 ($879)
- 4 Open-market sale Director sold 13,333 shares at $3.77 ($50,291)
- 144 Insider Sale of Securities
- 4 Insider Changes in Ownership
- 8-K Event Executive or director change · Regulation FD disclosure
- 4 Grant or award Director acquired 108,024 shares (grant or award)
Page 4 of 28 · 548 filings